{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:00:03Z","timestamp":1790132403865,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejso.2026.112129","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:28:51Z","timestamp":1789774131000},"page":"112129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Total neoadjuvant therapy for organ preservation in rectal cancer: Interpreting heterogeneous trial evidence"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7982-4349","authenticated-orcid":false,"given":"C\u00e9dric","family":"Schraepen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"D'Hoore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Coeckelberghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Bislenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0364-682X","authenticated-orcid":false,"given":"Karin","family":"Haustermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertjan","family":"Rasschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Dekervel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Tejpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-4582","authenticated-orcid":false,"given":"Raphaela","family":"Dresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7331-3660","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Broeckhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1200-387X","authenticated-orcid":false,"given":"Albert","family":"Wolthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ejso.2026.112129_bib1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2026.112129_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112129_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.112129_bib4","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/annonc\/mdq616","article-title":"Adjuvant chemotherapy for rectal cancer","volume":"21","author":"Bujko","year":"2010","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.112129_bib5","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41416-020-0989-1","article-title":"Association between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resection","volume":"123","author":"He","year":"2020","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2026.112129_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.112129_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.5445","article-title":"Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO\/ARO\/AIO-12 randomized clinical trial","volume":"8","author":"Fokas","year":"2022","journal-title":"JAMA Oncol"},{"issue":"15_suppl","key":"10.1016\/j.ejso.2026.112129_bib8","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1200\/JCO.2020.38.15_suppl.4008","article-title":"Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial","volume":"38","author":"Garcia-Aguilar","year":"2020","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.ejso.2026.112129_bib9","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter randomized phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.ejso.2026.112129_bib10","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12","volume":"37","author":"Fokas","year":"2019","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.112129_bib11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","article-title":"Long-course preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study","volume":"30","author":"Cise\u0142","year":"2019","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112129_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SLA.0000000000004499","article-title":"MRI-diagnosed tumour deposits and EMVI status have superior prognostic accuracy to current clinical TNM staging in rectal cancer","volume":"276","author":"Lord","year":"2022","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2026.112129_bib13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/SLA.0000000000005507","article-title":"Intentional watch-and-wait or organ preservation surgery following neoadjuvant chemoradiotherapy plus consolidation CAPEOX for MRI-defined low-risk rectal cancer: findings from a prospective phase 2 trial (PKUCH-R01)","volume":"277","author":"Wang","year":"2023","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2026.112129_bib14","first-page":"276","article-title":"Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?","volume":"5","author":"Simha","year":"2014","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.112129_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/SLA.0000000000005799","article-title":"Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial","volume":"278","author":"Dijkstra","year":"2023","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2026.112129_bib16","first-page":"456","article-title":"Short-course radiotherapy versus long-course radio-chemotherapy as neoadjuvant treatment for locally advanced rectal cancer: meta-analysis from a toxicity perspective","volume":"16","author":"Liscu","year":"2021","journal-title":"Maedica"},{"key":"10.1016\/j.ejso.2026.112129_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101964","article-title":"How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement","volume":"84","author":"Nagtegaal","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"15","key":"10.1016\/j.ejso.2026.112129_bib17","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.3390\/cancers15153869","article-title":"Preoperative radiotherapy with a simultaneous integrated boost compared to chemoradiotherapy for cT3\u20134 rectal cancer: long-term results of a multicenter randomized study","volume":"15","author":"Engels","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ejso.2026.112129_bib18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early rectal adenocarcinoma (OPERA): a phase 3 randomised controlled trial","volume":"8","author":"G\u00e9rard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2026.112129_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yasu.2021.05.007","article-title":"Watch-and-wait management for rectal cancer after clinical complete response to neoadjuvant therapy","volume":"55","author":"Yuval","year":"2021","journal-title":"Adv Surg"},{"issue":"4","key":"10.1016\/j.ejso.2026.112129_bib20","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/cancers15041016","article-title":"Does the gain of total neoadjuvant therapy outweigh the harm in rectal cancer? Importance of the ATRESS phenomenon: a systematic review","volume":"15","author":"Socha","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"31","key":"10.1016\/j.ejso.2026.112129_bib21","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.2016.67.6049","article-title":"Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer (GRECCAR-6)","volume":"34","author":"Lefevre","year":"2016","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.112129_bib22","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s00384-022-04268-7","article-title":"Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer","volume":"37","author":"Chen","year":"2022","journal-title":"Int J Colorectal Dis"},{"issue":"7","key":"10.1016\/j.ejso.2026.112129_bib23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/bjs.9112","article-title":"Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer","volume":"100","author":"Sloothaak","year":"2013","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.112129_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s13063-017-2085-2","article-title":"A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker (TRIGGER)","volume":"18","author":"Battersby","year":"2017","journal-title":"Trials"},{"issue":"9","key":"10.1016\/j.ejso.2026.112129_bib26","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ejso.2020.04.014","article-title":"Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians","volume":"46","author":"van der Valk","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.112129_bib27","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/DCR.0000000000001166","article-title":"Patient and physician preferences for nonoperative management for low rectal cancer: is it a reasonable treatment option?","volume":"61","author":"Kennedy","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.ejso.2026.112129_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.scrs.2022.100900","article-title":"Neoadjuvant and adjuvant therapy for local excision of rectal cancer","volume":"33","author":"Feferman","year":"2022","journal-title":"Semin Colon Rectal Surg"},{"issue":"11","key":"10.1016\/j.ejso.2026.112129_bib29","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1111\/codi.15838","article-title":"Burden of disease experienced by patients following a watch-and-wait policy for locally advanced rectal cancer: a qualitative study","volume":"23","author":"Pennings","year":"2021","journal-title":"Colorectal Dis"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326007481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326007481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:07:48Z","timestamp":1790129268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326007481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0748798326007481"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112129","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total neoadjuvant therapy for organ preservation in rectal cancer: Interpreting heterogeneous trial evidence","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112129"}}